In breast cancer, it was observed that MID2 expression exhibited a notable upregulation and a positive correlation with stage, Ki67 protein expression, and poor prognosis, promoting cancer cell proliferation (Wang et al., 2016). This evidence concerns the gene MKI67 and breast carcinoma.